Developer docs
API playgroundTry for free, no card

Search company profiles

BioSculpture Technology

Full company profile

uuid0005un3

Namestring
BioSculpture Technology
Legal namestring
BioSculpture Technology, Inc.
Company typeenum
Private
Founded yearint
2001
Descriptiontext

BioSculpture Technology, Inc. is a privately-held medical device company founded in 2001 as a spin-off from Rocin Laboratories, Inc., specializing in power-assisted liposuction systems built around its proprietary Twin Cannula Assisted Liposuction (TCAL) technology. The company's flagship Airbrush Liposculptor product line uses a tube-within-a-tube design in which an inner cannula is ensheathed within a slotted outer cannula, eliminating the battering ram effect of conventional single-cannula systems, reducing surgeon fatigue, and enabling controlled removal of 10+ pounds of fat in a single outpatient procedure, with reported 30%+ reductions in operating surgical times.

The company's product portfolio includes the Airbrush Liposculptor II and III hand pieces, the Intellimotion digital signal processor controller, RadioSurgery modules, compressors, cannula sets, and an FDA-cleared Multicore Quick Connector. BioSculpture holds 23+ U.S. patents with 21 pending applications and is developing EVL (Endoscopic Visceral Lipectomy), a patented minimally invasive method targeting obesity, metabolic syndrome, and type 2 diabetes. The company sells through manufacturer representatives covering U.S. territories plus Canada, Italy, Morocco, Taiwan, and Korea, and operates a direct e-commerce storefront. Revenue is generated through one-time hardware sales, licensing royalties (including to former OEM partners NuMed, Byron Medical, and Mentor), and professional services, though the current product catalogue is listed as unavailable while production is being retooled to a next-generation electrical TCAL system.

Short descriptiontext

BioSculpture Technology is a privately-held medical device company that designs, patents, and manufactures FDA-cleared Twin Cannula Assisted Liposuction (TCAL) systems and accessories for plastic and cosmetic surgeons, while developing endoscopic visceral lipectomy technology for obesity and metabolic disease treatment.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWest Palm Beach, United States
HQ citystring
West Palm Beach
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
power-assisted liposuction devices, medical device manufacturing, liposuction cannula systems, body contouring equipment, surgical adipose aspiration
Industry1 code
1Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
CodeHLAHADANPrimaryYes
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Liposuction Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of FDA-cleared Airbrush Liposculpture systems, Intellimotion controllers, cannula sets, and accessories to plastic/cosmetic surgeons. Products include the Airbrush Liposculptor II, RadioSurgery Module, and Compressor.

biosculpturetechnology.com
2Licensing Royalties
TypeLicensing Royalties
Description

Exclusive licensee of tissue aspiration and processing portfolio from parent company Rocin Laboratories, Inc. The company also licenses its technology to other manufacturers (NuMed, Byron Medical, Mentor).

biosculpturetechnology.com
3Regulation D Private Placement
TypeOne Time License
Description

Exempt offering of securities under Regulation D with total offering amount of $10 million for expansion and development.

sec.gov
4Tier 2 Regulation A Public Offering
TypeOne Time License
Description

SEC-qualified public offering terminated August 31, 2017. Offered 1,428,571 common shares at $3.50 per share to fund EVL development and commercialization.

biosculpturetechnology.com
5Professional Services
TypeProfessional Services
Description

Warranty repairs, extended service contracts, and physician referral services for Airbrush-certified surgeons.

biosculpturetechnology.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Pricing details6 tiers
1Airbrush Liposculptor II (Model LS-HP-AB-102)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Product currently unavailable as production is being retooled to next generation IIE version

biosculpturetechnology.com
2Intellimotion Controller (Model LS-PC-BB-101)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Product currently unavailable during production transition

biosculpturetechnology.com
3Airbrush RadioSurgery Module (Model LS-EC-BB-101)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Accessory module for use with Intellimotion Controller - unavailable

biosculpturetechnology.com
4Cannula Sets (Various Models)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Outer cannulas (5.1-8.1mm), Inner uncoated (4.5-7.5mm), Inner coated (4.0-7.0mm) - reusable instruments

biosculpturetechnology.com
5Regulation A Common Shares
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

1,428,571 common shares at $3.50 per share; minimum investment 200 shares ($700); sold in even lots of 100 shares. Offering terminated August 31, 2017.

biosculpturetechnology.com
6Airbrush Compressor (Model LS-AC-BB-101)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Compact, low-noise compressor for self-contained air source - unavailable

biosculpturetechnology.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Airbrush Liposculpture
Description

Twin Cannula Assisted Liposuction (TCAL) power-assisted liposuction system for body sculpting procedures

biosculpturetechnology.com
+2 more records
Core offering1 text field

BioSculpture Technology designs, manufactures, and sells FDA-cleared power-assisted liposuction medical devices for plastic and cosmetic surgeons. Its core offering is the Airbrush Liposculptor family built on proprietary Twin Cannula Assisted Liposuction (TCAL) technology, paired with the Intellimotion digital controller and a line of disposable cannula sets and accessories. The company is also developing the Endoscopic Visceral Lipectomy (EVL) system for visceral fat removal targeting the obesity market.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 30%+ reduction in operating surgical times
+2 more records
Product overview1 text field

BioSculpture Technology offers a modular system of medical devices for power-assisted liposuction and body sculpting. The core product line centers on the Airbrush® Liposculpture system, which includes the twin-cannula assisted liposuction (TCAL) hand pieces (Airbrush® Liposculptor, II, III, and IIE variants), supported by the Intellimotion® Controller, specialized cannula sets, and accessories including the RadioSurgery Module and Compressor. The company also provides Multicore Quick Connectors for integrated connectivity and is developing EVL (Endoscopic Visceral Lipectomy) technology for visceral fat removal as a treatment for obesity and metabolic conditions. The products range from FDA-cleared commercial devices to products in various stages of development.

Product and service9 records
1Airbrush Liposculptor (original)
CategoryLiposuction capital equipment
Description

Power-assisted liposuction capital system using Twin Cannula Assisted Liposuction (TCAL) technology, used by plastic and cosmetic surgeons for fat extraction and body contouring.

2Airbrush Liposculptor II
CategoryLiposuction capital equipment
Description

Second-generation power-assisted liposuction device with Twin Cannula Assisted Liposuction technology and FDA 510(k) clearance, targeted at plastic and cosmetic surgeons and surgical hospitals.

3Airbrush Liposculptor III
CategoryLiposuction capital equipment
Description

Latest-generation Airbrush Liposculptor power-assisted liposuction system, integrating the Twin Cannula Assisted Liposuction (TCAL) architecture and Intellimotion controller, used by plastic and cosmetic surgeons for fat extraction and body contouring.

4Intellimotion Controller
CategoryLiposuction capital equipment
Description

Digital controller for the Airbrush Liposculptor family that regulates Twin Cannula Assisted Liposuction motion and procedure parameters, providing digital signal processing control of the liposuction device.

5Cannula Sets (disposable)
CategoryLiposuction consumables
Description

Disposable Twin Cannula Assisted Liposuction cannula sets used as per-procedure consumables with the Airbrush Liposculptor system, sold to surgical practices and hospitals.

6Multicore Quick Connector
CategoryLiposuction accessories
Description

Multi-line quick connector accessory for the Airbrush Liposculptor system that enables rapid, integrated connection of cannulas and tubing during liposuction procedures.

7RadioSurgery Module
CategoryLiposuction accessories
Description

RadioSurgery accessory module for the Airbrush Liposculptor system that adds electrosurgical capability to liposuction procedures performed by plastic and cosmetic surgeons.

8Airbrush Compressor
CategoryLiposuction accessories
Description

Compressor accessory that supplies pneumatic drive for the Airbrush Liposculptor system, completing the Twin Cannula Assisted Liposuction (TCAL) hardware offering for surgical practices.

9Endoscopic Visceral Lipectomy (EVL)
CategoryVisceral fat removal / obesity intervention device
Description

In-development endoscopic visceral lipectomy device extending BioSculpture's Twin Cannula Assisted Liposuction (TCAL) technology to removal of visceral fat for obesity treatment, intended for use by surgeons and bariatric specialists.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed technology to NuMed for distribution of Power Cannula - a reusable unit powered by a small hand-held low voltage electrical motor. Nu-Med distributed the device as Byron Medical acquired Mentor which was acquired by Ethicon.

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed ARC (Systems Reciprocating Cannula) technology to Byron Medical. Manufacturing disposable gas-powered assembly driven by vacuum system for Psi-Tec Systems Aspiration Platform. Byron Medical was subsequently acquired by Mentor.

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Acquired Byron Medical and continued distribution of powered liposuction technology. Subsequently acquired by Ethicon, creating a major medical device conglomerate pathway for the technology.

4Rocin Laboratories, Inc.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Parent company and IP source. BioSculpture Technology was created as an independent company to exclusively license the tissue aspiration and processing portfolio from Rocin Laboratories. Rocin was founded by Dr. Cucin 20 years ago and maintains a worldwide patent portfolio including Skin Care Division, Rocin Press, Lipotome Systems, and Surgical Tools Division.

biosculpturetechnology.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Media coverage and interview partnerships at investment conferences. SNNLive conducted video interviews with CEO Dr. Robert Cucin during Media Day 2016 at WestPark Capital in New York City.

6CEO Clips
Strategic tierMinorTypeGTM or Marketing Partner
Description

Documentary series profiling innovative publicly traded companies in North America featured BioSculpture Technology on The Documentary Channel July 3-16, 2017.

biosculpturetechnology.com
Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor in power-assisted liposuction (PAL) systems. MicroAire's PAL device competes head-to-head against BioSculpture's TCAL technology for the same plastic surgeon customers performing body contouring procedures.

TypeBroad incumbent
Description

Previously licensed BioSculpture/Byron Medical's ARC powered-liposuction technology and now operates inside J&J's MedTech platform. Competes broadly across aesthetic surgery and leverages vastly greater commercial and R&D resources.

TypeDirect peer
Description

Long-established manufacturer of power-assisted liposuction equipment and tumescent infiltration systems serving the same plastic and cosmetic surgeon customer base as BioSculpture.

TypeDirect peer
Description

Markets VASERlipo, an ultrasound-assisted liposuction system directly competitive with BioSculpture's TCAL, and also offers non-invasive body contouring platforms (Liposonix, Thermage) addressing adjacent demand.

TypeBroad incumbent
Description

Public aesthetic medical device company offering BodyTite, Morpheus8, and related body contouring/liposuction platforms. Competes for the same plastic surgeon budgets and accounts with broader minimally invasive product lines.

TypeBroad incumbent
Description

Aesthetic medical device platform within Hologic covering laser- and RF-based body contouring systems. Targets the same cosmetic surgery customer base as BioSculpture, though via non-powered-liposuction modalities.

TypeEmerging player
Description

Markets Renuvion (J-Plasma) for subdermal tissue coagulation in body contouring procedures. Competes for share of cosmetic surgery workflows that might otherwise use powered liposuction systems like BioSculpture's TCAL.

TypeRegional player
Description

German manufacturer of water-jet assisted liposuction (WAL) systems competing with BioSculpture in the powered-liposuction category. Operates primarily in Europe with limited direct US presence.

TypeEmerging player
Description

CoolSculpting represents a non-invasive cryolipolysis alternative that diverts demand away from powered liposuction procedures. Relevant peer as the dominant non-surgical body contouring modality competing for the same patient population.

TypeBroad incumbent
Description

Global aesthetic device manufacturer offering laser- and RF-assisted body contouring and lipolysis systems (e.g., Accent, BeautiFill). Targets the same plastic/cosmetic surgery segment as BioSculpture with broader modality coverage.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioSculpture Technology

Liposuction Medical Devicesbiosculpturetechnology.com

BioSculpture Technology is a privately-held medical device company that designs, patents, and manufactures FDA-cleared Twin Cannula Assisted Liposuction (TCAL) systems and accessories for plastic and cosmetic surgeons, while developing endoscopic visceral lipectomy technology for obesity and metabolic disease treatment.

What BioSculpture Technology does

BioSculpture Technology, Inc. is a privately-held medical device company founded in 2001 as a spin-off from Rocin Laboratories, Inc., specializing in power-assisted liposuction systems built around its proprietary Twin Cannula Assisted Liposuction (TCAL) technology. The company's flagship Airbrush Liposculptor product line uses a tube-within-a-tube design in which an inner cannula is ensheathed within a slotted outer cannula, eliminating the battering ram effect of conventional single-cannula systems, reducing surgeon fatigue, and enabling controlled removal of 10+ pounds of fat in a single outpatient procedure, with reported 30%+ reductions in operating surgical times.

The company's product portfolio includes the Airbrush Liposculptor II and III hand pieces, the Intellimotion digital signal processor controller, RadioSurgery modules, compressors, cannula sets, and an FDA-cleared Multicore Quick Connector. BioSculpture holds 23+ U.S. patents with 21 pending applications and is developing EVL (Endoscopic Visceral Lipectomy), a patented minimally invasive method targeting obesity, metabolic syndrome, and type 2 diabetes. The company sells through manufacturer representatives covering U.S. territories plus Canada, Italy, Morocco, Taiwan, and Korea, and operates a direct e-commerce storefront. Revenue is generated through one-time hardware sales, licensing royalties (including to former OEM partners NuMed, Byron Medical, and Mentor), and professional services, though the current product catalogue is listed as unavailable while production is being retooled to a next-generation electrical TCAL system.

BioSculpture Technology firmographics

Firmographics
Name
BioSculpture Technology
Legal name
BioSculpture Technology, Inc.
Website
https://biosculpturetechnology.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
BioSculpture Technology is a privately-held medical device company that designs, patents, and manufactures FDA-cleared Twin Cannula Assisted Liposuction (TCAL) systems and accessories for plastic and cosmetic surgeons, while developing endoscopic visceral lipectomy technology for obesity and metabolic disease treatment.
Ownership category
akta.pro rank

BioSculpture Technology industry classification

Industry
Product category
Liposuction Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

  • Power-assisted liposuction devices
  • Medical device manufacturing
  • Liposuction cannula systems
  • Body contouring equipment
  • Surgical adipose aspiration

Where BioSculpture Technology is headquartered

Location

Headquarters

HQ city
West Palm Beach
HQ country
United States
HQ region
North America

Offices2 records

Markets served

BioSculpture Technology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales: Sale of FDA-cleared Airbrush Liposculpture systems, Intellimotion controllers, cannula sets, and accessories to plastic/cosmetic surgeons. Products include the Airbrush Liposculptor II, RadioSurgery Module, and Compressor.
  2. Licensing Royalties: Exclusive licensee of tissue aspiration and processing portfolio from parent company Rocin Laboratories, Inc. The company also licenses its technology to other manufacturers (NuMed, Byron Medical, Mentor).
  3. Regulation D Private Placement: Exempt offering of securities under Regulation D with total offering amount of $10 million for expansion and development.
  4. Tier 2 Regulation A Public Offering: SEC-qualified public offering terminated August 31, 2017. Offered 1,428,571 common shares at $3.50 per share to fund EVL development and commercialization.
  5. Professional Services: Warranty repairs, extended service contracts, and physician referral services for Airbrush-certified surgeons.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goAirbrush Liposculptor II (Model LS-HP-AB-102)
One time/ perpetual licensePay-as-you-goIntellimotion Controller (Model LS-PC-BB-101)
One time/ perpetual licensePay-as-you-goAirbrush RadioSurgery Module (Model LS-EC-BB-101)
Unit PricingPay-as-you-goCannula Sets (Various Models)
One time/ perpetual licensePay-as-you-goRegulation A Common Shares
One time/ perpetual licensePay-as-you-goAirbrush Compressor (Model LS-AC-BB-101)

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

BioSculpture Technology product offering

Product offering

Core offering

BioSculpture Technology designs, manufactures, and sells FDA-cleared power-assisted liposuction medical devices for plastic and cosmetic surgeons. Its core offering is the Airbrush Liposculptor family built on proprietary Twin Cannula Assisted Liposuction (TCAL) technology, paired with the Intellimotion digital controller and a line of disposable cannula sets and accessories. The company is also developing the Endoscopic Visceral Lipectomy (EVL) system for visceral fat removal targeting the obesity market.

Product overview

BioSculpture Technology offers a modular system of medical devices for power-assisted liposuction and body sculpting. The core product line centers on the Airbrush® Liposculpture system, which includes the twin-cannula assisted liposuction (TCAL) hand pieces (Airbrush® Liposculptor, II, III, and IIE variants), supported by the Intellimotion® Controller, specialized cannula sets, and accessories including the RadioSurgery Module and Compressor. The company also provides Multicore Quick Connectors for integrated connectivity and is developing EVL (Endoscopic Visceral Lipectomy) technology for visceral fat removal as a treatment for obesity and metabolic conditions. The products range from FDA-cleared commercial devices to products in various stages of development.

Differentiator

Problem solved

Functional benefit

Brands

  • Airbrush Liposculpture: Twin Cannula Assisted Liposuction (TCAL) power-assisted liposuction system for body sculpting procedures
  • Intellimotion
  • EVL (Endoscopic Visceral Lipectomy)

Products and services

  • Airbrush Liposculptor (original) Power-assisted liposuction capital system using Twin Cannula Assisted Liposuction (TCAL) technology, used by plastic and cosmetic surgeons for fat extraction and body contouring.
  • Airbrush Liposculptor II Second-generation power-assisted liposuction device with Twin Cannula Assisted Liposuction technology and FDA 510(k) clearance, targeted at plastic and cosmetic surgeons and surgical hospitals.
  • Airbrush Liposculptor III Latest-generation Airbrush Liposculptor power-assisted liposuction system, integrating the Twin Cannula Assisted Liposuction (TCAL) architecture and Intellimotion controller, used by plastic and cosmetic surgeons for fat extraction and body contouring.
  • Intellimotion Controller Digital controller for the Airbrush Liposculptor family that regulates Twin Cannula Assisted Liposuction motion and procedure parameters, providing digital signal processing control of the liposuction device.
  • Cannula Sets (disposable) Disposable Twin Cannula Assisted Liposuction cannula sets used as per-procedure consumables with the Airbrush Liposculptor system, sold to surgical practices and hospitals.
  • Multicore Quick Connector Multi-line quick connector accessory for the Airbrush Liposculptor system that enables rapid, integrated connection of cannulas and tubing during liposuction procedures.
  • RadioSurgery Module RadioSurgery accessory module for the Airbrush Liposculptor system that adds electrosurgical capability to liposuction procedures performed by plastic and cosmetic surgeons.
  • Airbrush Compressor Compressor accessory that supplies pneumatic drive for the Airbrush Liposculptor system, completing the Twin Cannula Assisted Liposuction (TCAL) hardware offering for surgical practices.
  • Endoscopic Visceral Lipectomy (EVL) In-development endoscopic visceral lipectomy device extending BioSculpture's Twin Cannula Assisted Liposuction (TCAL) technology to removal of visceral fat for obesity treatment, intended for use by surgeons and bariatric specialists.

Quantifiable outcome

  • 30%+ reduction in operating surgical times
  • +2 more outcomes

Companies that use BioSculpture Technology

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

BioSculpture Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

BioSculpture Technology partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • NuMed (Power Cannula)minorOEM/ Whitelabel/ Licensing PartnerLicensed technology to NuMed for distribution of Power Cannula - a reusable unit powered by a small hand-held low voltage electrical motor. Nu-Med distributed the device as Byron Medical acquired Mentor which was acquired by Ethicon.
  • Byron MedicalminorOEM/ Whitelabel/ Licensing PartnerLicensed ARC (Systems Reciprocating Cannula) technology to Byron Medical. Manufacturing disposable gas-powered assembly driven by vacuum system for Psi-Tec Systems Aspiration Platform. Byron Medical was subsequently acquired by Mentor.
  • MentorminorOEM/ Whitelabel/ Licensing PartnerAcquired Byron Medical and continued distribution of powered liposuction technology. Subsequently acquired by Ethicon, creating a major medical device conglomerate pathway for the technology.
  • Rocin Laboratories, Inc.coreStrategic or Co-development PartnerParent company and IP source. BioSculpture Technology was created as an independent company to exclusively license the tissue aspiration and processing portfolio from Rocin Laboratories. Rocin was founded by Dr. Cucin 20 years ago and maintains a worldwide patent portfolio including Skin Care Division, Rocin Press, Lipotome Systems, and Surgical Tools Division.
  • SNNLive / WestPark CapitalminorGTM or Marketing PartnerMedia coverage and interview partnerships at investment conferences. SNNLive conducted video interviews with CEO Dr. Robert Cucin during Media Day 2016 at WestPark Capital in New York City.
  • CEO ClipsminorGTM or Marketing PartnerDocumentary series profiling innovative publicly traded companies in North America featured BioSculpture Technology on The Documentary Channel July 3-16, 2017.

Scale indicators10 records

Recent moves10 records

Expansion highlights6 records

BioSculpture Technology competitors and assessment

Company assessment

Direct peers

  • MicroAire Surgical Instruments: Direct competitor in power-assisted liposuction (PAL) systems. MicroAire's PAL device competes head-to-head against BioSculpture's TCAL technology for the same plastic surgeon customers performing body contouring procedures.
  • Wells Johnson Company: Long-established manufacturer of power-assisted liposuction equipment and tumescent infiltration systems serving the same plastic and cosmetic surgeon customer base as BioSculpture.
  • Solta Medical (Bausch Health): Markets VASERlipo, an ultrasound-assisted liposuction system directly competitive with BioSculpture's TCAL, and also offers non-invasive body contouring platforms (Liposonix, Thermage) addressing adjacent demand.

Broad incumbents

  • Mentor (Ethicon, Johnson & Johnson MedTech): Previously licensed BioSculpture/Byron Medical's ARC powered-liposuction technology and now operates inside J&J's MedTech platform. Competes broadly across aesthetic surgery and leverages vastly greater commercial and R&D resources.
  • InMode: Public aesthetic medical device company offering BodyTite, Morpheus8, and related body contouring/liposuction platforms. Competes for the same plastic surgeon budgets and accounts with broader minimally invasive product lines.
  • Cynosure (Hologic): Aesthetic medical device platform within Hologic covering laser- and RF-based body contouring systems. Targets the same cosmetic surgery customer base as BioSculpture, though via non-powered-liposuction modalities.
  • Alma Lasers: Global aesthetic device manufacturer offering laser- and RF-assisted body contouring and lipolysis systems (e.g., Accent, BeautiFill). Targets the same plastic/cosmetic surgery segment as BioSculpture with broader modality coverage.

Emerging players

  • Apyx Medical: Markets Renuvion (J-Plasma) for subdermal tissue coagulation in body contouring procedures. Competes for share of cosmetic surgery workflows that might otherwise use powered liposuction systems like BioSculpture's TCAL.
  • AbbVie (Allergan Aesthetics / CoolSculpting): CoolSculpting represents a non-invasive cryolipolysis alternative that diverts demand away from powered liposuction procedures. Relevant peer as the dominant non-surgical body contouring modality competing for the same patient population.

Regional players

  • Human Med (Wasserstrahl-Technik): German manufacturer of water-jet assisted liposuction (WAL) systems competing with BioSculpture in the powered-liposuction category. Operates primarily in Europe with limited direct US presence.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

BioSculpture Technology social profiles

Digital presence

BioSculpture Technology compliance and trust

Trust signal

Compliance3 records

BioSculpture Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioSculpture Technology leadership team

Management profile

Number of profiles

Profiles9 records

BioSculpture Technology funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioSculpture Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioSculpture Technology

What does BioSculpture Technology do?

BioSculpture Technology designs, manufactures, and sells FDA-cleared power-assisted liposuction medical devices for plastic and cosmetic surgeons. Its core offering is the Airbrush Liposculptor family built on proprietary Twin Cannula Assisted Liposuction (TCAL) technology, paired with the Intellimotion digital controller and a line of disposable cannula sets and accessories. The company is also developing the Endoscopic Visceral Lipectomy (EVL) system for visceral fat removal targeting the obesity market.

Is BioSculpture Technology a public or private company?

BioSculpture Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BioSculpture Technology founded?

BioSculpture Technology was founded in 2001. It employs 11 to 50 people.

Where is BioSculpture Technology based?

BioSculpture Technology is headquartered in West Palm Beach, United States, in the North America region.

How does BioSculpture Technology make money?

Five revenue lines are on record. Medical Device Sales are the primary driver. The others are licensing Royalties, regulation D Private Placement, tier 2 Regulation A Public Offering and professional Services.

Who are BioSculpture Technology's main competitors?

Direct peers on record are MicroAire Surgical Instruments, Wells Johnson Company and Solta Medical (Bausch Health). Broad incumbents are Mentor (Ethicon, Johnson & Johnson MedTech), InMode, Cynosure (Hologic) and Alma Lasers. Emerging players are Apyx Medical and AbbVie (Allergan Aesthetics / CoolSculpting). Human Med (Wasserstrahl-Technik) is listed as a regional player.

Does BioSculpture Technology have an API?

No public API is recorded for BioSculpture Technology.

What industry is BioSculpture Technology in?

BioSculpture Technology's product category is Liposuction Medical Devices. Its primary akta.pro industry code is HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SecSEC FORM DBioSculpture Technology, Inc. filed a Form D with the SEC on November 23, 2022, announcing an exempt securities offering under Rule 506(b). The company intends to raise up to $10 million in equity securities, having already sold $26,000 of the total amount as of the filing date.3dprintHow One Company is Defeating Obesity with 3D Printing-Based Bariatric Procedures - 3DPrint.comBioSculpture Technology, led by Dr. Robert Cucin, has developed 3D printing-based surgical instruments for obesity treatment, specifically for liposuction procedures. The company uses 3D imaging and printing to create custom-built equipment tailored to individual patient anatomy, which it claims reduces operation time and improves safety by allowing fat removal through smaller incisions. According to Dr. Cucin, the technology enables surgeons to extract fat in ways that were previously only possible through cutting.GlobeNewswireBioSculpture Technology Inc. to Focus Research and Development Efforts to Rollout Endoscopic Visceral Lipectomy ("EVL") to Address the $2T Yearly Obesity-Related Disease MarketBioSculpture Technology announced it will refocus on the bariatric market to roll out its Endoscopic Visceral Lipectomy (EVL) device. The company expects a full go-to-market within 12 months to target the $2 trillion obesity-related disease market. EVL is expected to permanently remove visceral fat without cutting into the bowel or stomach.GlobeNewswireCEO Robert L. Cucin, M.D. of BioSculpture Technology, Inc. to Be Interviewed on Clear Channel - iHeart Business Talk Radio's "The Trader's Network"BioSculpture Technology CEO Robert L. Cucin, M.D. will be interviewed live on Clear Channel's "The Trader's Network" on April 11, 2015. The company's device targets endoscopic removal of visceral fat for obesity and metabolic syndrome treatment.